Bullish
This article examines Merck & Co.'s long-term growth strategy, emphasizing its reliance on the blockbuster cancer drug Keytruda and a robust late-stag...
Neutral
The FDA has expanded the label for Merck's Capvaxive pneumococcal shot to include at-risk children and adolescents aged 2-17 with chronic conditions, ...
Neutral
Merck announced that the U.S. FDA has approved a label expansion for its pneumococcal vaccine, Capvaxive. The expanded indication now includes immuniz...
Neutral
State of Wisconsin Investment Board trimmed its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 7.6% in the fourth quarter, Holdings ...
Neutral
Siemens Fonds Invest GmbH decreased its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 8.8% during the fourth quarter, Holdings C...
Neutral
Merck & Co Inc (MRK) saw its stock price drop by 3.13% on June 15, driven by several factors including proposed CMS drug price negotiations, setbacks ...
Neutral
Mariner LLC increased its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 8.9% in the fourth quarter, according to its most recent...
Neutral
Arrowstreet Capital Limited Partnership lessened its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 46.8% in the 4th quarter, Holdin...
Bullish
Storgate LLC initiated a new position in Merck & Co., Inc. during the fourth quarter, purchasing 9,673 shares valued at approximately $1.0 million, ma...
Bullish
Merck Animal Health has entered into a definitive agreement to acquire TARGAN, an agtech developer specializing in high-speed automated biodevices for...
Bullish
Merck Animal Health is set to acquire TARGAN, an agricultural technology company specializing in automated biodevice solutions for the poultry industr...
Bullish
Zions Bancorporation National Association UT significantly increased its stake in Merck & Co., Inc. during the fourth quarter, boosting its holdings b...
Bullish
Merck Animal Health has announced an agreement to acquire TARGAN, a biodevice solutions developer specializing in the poultry industry, for an undiscl...
Bullish
M Holdings Securities Inc. has made a new $8.26 million investment in Merck & Co., Inc. by purchasing 78,499 shares during the fourth quarter. Institu...
Neutral
Brandes Investment Partners LP lifted its position in Merck & Co., Inc. (NYSE:MRK – Free Report) by 1.9% during the fourth quarter, according to its m...
Bullish
Merck & Co. is a leading pharmaceutical company, with its growth significantly driven by the blockbuster cancer drug Keytruda and a strong vaccines bu...
Bullish
ING Groep NV reduced its stake in Merck & Co., Inc. ($MRK) by 8.1% in the fourth quarter, selling 69,433 shares. Despite this, Merck reported strong q...
Bullish
Los Angeles Capital Management LLC significantly increased its stake in Merck & Co., Inc. (MRK) by 12.7% in the fourth quarter, now holding 3.85 milli...
Bullish
Vestcor Inc reduced its stake in Merck & Co., Inc. by 8.1% in the fourth quarter, selling 22,707 shares and retaining 258,377 shares valued at $27.2 m...
Bullish
Vise Technologies Inc. significantly increased its stake in Merck & Co., Inc. by 50.5% in the fourth quarter, holding 110,677 shares valued at $11.65 ...